Titan Medical and the Institute of Image-Guided Surgery of Strasbourg Announce the First Installation of SPORT Surgical Syste...
December 06 2017 - 6:30AM
Titan Medical Inc. (“Titan” or the “Company”)
(TSX:TMD) (OTCQB:TITXF), a medical device company focused on the
design, development and commercialization of a robotic surgical
system for application in minimally invasive surgery (MIS), and the
Institute of image-guided surgery (Institut Hospitalo-Universitaire
de Strasbourg: IHU Strasbourg) announce the installation of Titan
Medical’s SPORT Surgical System at IHU Strasbourg’s research
facility. This is the first SPORT installation in Europe and
the final planned installation at Titan’s Center of Excellence
sites for feasibility and validation studies to support regulatory
submissions. The studies at IHU Strasbourg are expected to commence
in the fourth quarter of 2017 and continue into 2018.
David McNally, President and CEO of Titan
Medical, said, “We are pleased to announce SPORT’s first European
installation at IHU Strasbourg, right on schedule. Following
Florida Hospital Nicholson Center in Orlando and Columbia
University Medical Center in New York, this is our final planned
installation at our Center of Excellence sites. We now have
achieved a critical milestone of success with installations of the
SPORT system at all three of our Center of Excellence sites before
the end of 2017. This is a significant positive step for Titan
Medical as we continue to deliver our stated milestones on time
with the end goal of commercializing the SPORT Surgical
System.”
“With successful first uses of the SPORT system
reported from the two U.S. Center of Excellence sites, we now
enthusiastically look forward to conducting the first of the
feasibility studies at IHU Strasbourg in the coming weeks,” added
Mr. McNally.
Prof. Jacques Marescaux, Chief Executive Officer
of IHU Strasbourg, said, “We are delighted that Titan Medical has
chosen IHU Strasbourg as its first European installation site for
feasibility and validation studies of the SPORT system. We look
forward to embarking on this exciting journey with Titan Medical
and feel confident that IHU’s exceptional clinical and research
expertise will provide a strong foundation for development of the
SPORT Surgical System throughout these studies.”
About the Institute of
Image-Guided Surgery / IHU Strasbourg,
France
The Institute of Image-Guided Surgery is a
unique medical and surgical center dedicated to the management of
digestive diseases. It develops innovative surgery to deliver
personalized patient care, combining the most advanced minimally
invasive techniques and the latest medical imaging methods.
The Institute is:
- A healthcare center offering personalized treatment
using the least invasive techniques;
- A research center gathering teams to design and
develop instruments and procedures for the future;
- An international training center for professionals
and students driven to learn the most advanced minimally invasive
practices; and
- An innovation hub to foster technology transfer through
industrial partnerships and creation of startups.
The Institute is a designated part of the
“Programme Investissements d’Avenir” and benefits from the
financial support of the French government managed by the “Agence
Nationale de la Recherche.” The Institute is also funded by the
Région Alsace, the Conseil Général du Bas-Rhin, the Communauté
urbaine de Strasbourg and the European Union.
For more information, please visit IHU
Strasbourg’s website at www.ihu-strasbourg.eu/ihu/en/.
About Titan Medical Inc.
Titan Medical Inc. is a Canadian public company
focused on research and development through to the planned
commercialization of computer-assisted robotic surgical
technologies for application in minimally invasive surgery. The
Company is currently developing the SPORT Surgical System, a
single-port robotic surgical system. The SPORT Surgical System is
comprised of a surgeon-controlled patient cart that includes a 3D
high definition vision system and multi-articulating instruments
for performing MIS procedures, and a surgeon workstation that
provides the surgeon with an advanced ergonomic interface to the
patient cart and a 3D endoscopic view inside the patient’s body
during MIS procedures. With the SPORT Surgical System, the Company
aims to pursue a broad set of surgical indications, including
general abdominal, gynecologic and urologic procedures.
For more information, please visit the Company’s
website at www.titanmedicalinc.com.
Forward-Looking Statements
This news release contains “forward-looking
statements” which reflect the current expectations of management of
the Company’s future growth, results of operations, performance and
business prospects and opportunities. Wherever possible, words such
as “may”, “would”, “could”, “will”, “anticipate”, “believe”,
“plan”, “expect”, “intend”, “estimate”, “potential for” and similar
expressions have been used to identify these forward-looking
statements. These statements reflect management’s current beliefs
with respect to future events and are based on information
currently available to management. Forward-looking statements
involve significant risks, uncertainties and assumptions. Many
factors could cause the Company’s actual results, performance or
achievements to be materially different from any future results,
performance or achievements that may be expressed or implied by
such forward-looking statements, including, without limitation,
those listed in the “Risk Factors” section of the Company’s Annual
Information Form dated March 31, 2017 (which may be viewed at
www.sedar.com). Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
statements prove incorrect, actual results, performance, or
achievements may vary materially from those expressed or implied by
the forward-looking statements contained in this news release.
These factors should be considered carefully, and prospective
investors should not place undue reliance on the forward-looking
statements. Although the forward-looking statements contained in
the news release are based upon what management currently believes
to be reasonable assumptions, the Company cannot assure prospective
investors that actual results, performance or achievements will be
consistent with these forward-looking statements.
Contacts:
LHA Investor Relations Kim Sutton Golodetz(212)
838-3777kgolodetz@lhai.com or Bruce
Voss(310) 691-7100 bvoss@lhai.com
Titan Medical (TSX:TMD)
Historical Stock Chart
From Apr 2024 to May 2024
Titan Medical (TSX:TMD)
Historical Stock Chart
From May 2023 to May 2024